DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 03 · Volume 33 · 1975 DOI: 10.1055/s-009-45085

Editorial

  • 403
  • National Conference on Thrombosis and Hemostasis, Dallas, Texas, 20.—22. November 1974

  • 405
    James Day, H; Mosesson, Michael W:

    Introduction

  • 406
  • 417
  • 426
    Nossel, Hymie L; Butler, Vincent P; Canfield, Robert E; Yudelman, Ian; Ti, Mary; Spanondis, Kalliope; Soland, Tove:

    Potential Use of Fibrinopeptide A Measurements in the Diagnosis and Management of Thrombosis

  • 435
  • 444
  • 457
  • 464
    Sasahara, Arthur A; Bell, William R; Simon, Toby L; Stengle, James M; Sherry, Sol:

    The Phase II Urokinase-Streptokinase Pulmonary Embolism Trial

  • Original Article

  • 477
  • 493
  • 501
  • 508
  • 519
  • 528
  • 540
  • 547
  • 553
    Østerud, B; Laake, K; Prydz, H:

    The Activation of Human Factor IX

  • 564
  • 573
  • 586
  • International Committee on Thrombosis and Haemostasis Task Force

  • 597
  • 600
  • 606
  • 610
  • 617
    Kingdon, H. S; Lundblad, R. L; Veltkamp, J. J; Aronson, D. L:

    Potentially Thrombogenic Materials in Factor IX Concentrates

  • 632
    Cash, John D; Dalton, Rodger G; Middleton, Sarah; Smith, James K:

    Studies on the Thrombogenicity of Scottish Factor IX Concentrates in Dogs

  • 640
  • 645
  • 648
  • International Committee on Thrombosis and Haemostasis Basel, 8.—11. September 1974 Subcommittee on Clinical Investigations

  • 655
  • Letter to the Editor

  • 664
    Coeugniet, E. G; Søeberg, B:

    Dipyridamole

  • 666
    Loeliger, E. A; Boekhout-Mussert, M. J; Bieger, R:

    Prolonged Continuous Heparin Treatment

  • 667
    Dijk-Wierda, C. A. v; Loeliger, E. A:

    External Quality Control in The Netherlands

  • 668
  • 672
  • 674
    de Jonge, H; Loeliger, E. A:

    Action of Sulfinpyrazon